Breaking News Instant updates and real-time market news.

BWA

BorgWarner

$35.14 /

+0.73 (+2.12%)

10:05
12/19/18
12/19
10:05
12/19/18
10:05

BorgWarner extends agreement to be Official Turbocharger Partner of INDYCAR

BorgWarner and INDYCAR announced that BorgWarner will continue to be the Official Turbocharger Partner of the IndyCar Series with its Engineered for Racing turbocharger, through the 2020 season. BorgWarner's innovative engineering and materials expertise are race proven, with more than 1.25 million trouble-free miles since 2012, on high-speed oval tracks, road courses, street courses and short oval tracks.

BWA BorgWarner
$35.14 /

+0.73 (+2.12%)

12/13/18 Deutsche Bank
Deutsche Bank initiates auto sector with cautious view
12/13/18 Deutsche Bank
BorgWarner initiated with a Buy at Deutsche Bank
12/10/18 KeyBanc
BorgWarner initiated with a Sector Weight at KeyBanc
12/04/18 Jefferies
BorgWarner initiated with a Buy at Jefferies

TODAY'S FREE FLY STORIES

Earnings
Globant not providing a full year 2020 financial outlook » 16:18
08/13/20
08/13
16:18
08/13/20
16:18
GLOB

Globant

$180.50 /

+6.4 (+3.68%)

Due to the ongoing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GLOB Globant
$180.50 /

+6.4 (+3.68%)

GLOB Globant
$180.50 /

+6.4 (+3.68%)

07/28/20 Piper Sandler
Globant price target raised to $181 from $152 at Piper Sandler
07/17/20 Cowen
Globant price target raised to $165 from $128 at Cowen
07/03/20 Goldman Sachs
Globant price target raised to $167 from $147 at Goldman Sachs
05/22/20 Piper Sandler
Piper expands Software coverage, favors companies that drive automation
GLOB Globant
$180.50 /

+6.4 (+3.68%)

  • 05
    Jun
GLOB Globant
$180.50 /

+6.4 (+3.68%)

Earnings
Globant sees Q3 non-IFRS adjusted diluted EPS at least 58c, consensus 54c » 16:18
08/13/20
08/13
16:18
08/13/20
16:18
GLOB

Globant

$180.50 /

+6.4 (+3.68%)

Sees Q3 revenue at least…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLOB Globant
$180.50 /

+6.4 (+3.68%)

GLOB Globant
$180.50 /

+6.4 (+3.68%)

07/28/20 Piper Sandler
Globant price target raised to $181 from $152 at Piper Sandler
07/17/20 Cowen
Globant price target raised to $165 from $128 at Cowen
07/03/20 Goldman Sachs
Globant price target raised to $167 from $147 at Goldman Sachs
05/22/20 Piper Sandler
Piper expands Software coverage, favors companies that drive automation
GLOB Globant
$180.50 /

+6.4 (+3.68%)

  • 05
    Jun
GLOB Globant
$180.50 /

+6.4 (+3.68%)

Hot Stocks
Dillard's reports Q2 retail gross margin up 239bps » 16:18
08/13/20
08/13
16:18
08/13/20
16:18
DDS

Dillard's

$27.06 /

+0.195 (+0.73%)

The company reported no…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DDS Dillard's
$27.06 /

+0.195 (+0.73%)

DDS Dillard's
$27.06 /

+0.195 (+0.73%)

08/03/20 Wedbush
Dillard's price target raised to $26 from $19 at Wedbush
05/15/20 JPMorgan
Dillard's price target lowered to $23 from $32 at JPMorgan
05/07/20 Deutsche Bank
Dillard's price target lowered to $18 from $36 at Deutsche Bank
04/30/20 Wedbush
Dillard's price target lowered to $25 from $63 at Wedbush
DDS Dillard's
$27.06 /

+0.195 (+0.73%)

DDS Dillard's
$27.06 /

+0.195 (+0.73%)

DDS Dillard's
$27.06 /

+0.195 (+0.73%)

Earnings
Accolade reports Q1 EPS ($1.86), consensus (40c) » 16:17
08/13/20
08/13
16:17
08/13/20
16:17
ACCD

Accolade

$37.35 /

-0.49 (-1.29%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACCD Accolade
$37.35 /

-0.49 (-1.29%)

07/27/20 Baird
Accolade initiated with an Outperform at Baird
07/27/20
Fly Intel: Top five analyst initiations
07/27/20 SVB Leerink
Accolade initiated with a Market Perform at SVB Leerink
07/27/20 BofA
Accolade initiated with a Buy at BofA
  • 02
    Jul
ACCD Accolade
$37.35 /

-0.49 (-1.29%)

Earnings
Trevi Therapeutics reports Q2 net loss $7.38M » 16:17
08/13/20
08/13
16:17
08/13/20
16:17
TRVI

Trevi Therapeutics

$5.66 /

-0.93 (-14.11%)

As of June 30, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRVI Trevi Therapeutics
$5.66 /

-0.93 (-14.11%)

TRVI Trevi Therapeutics
$5.66 /

-0.93 (-14.11%)

07/13/20 Stifel
Trevi Therapeutics price target lowered to $10 from $14 at Stifel
TRVI Trevi Therapeutics
$5.66 /

-0.93 (-14.11%)

Earnings
Dillard's reports Q2 EPS (37c), consensus ($4.54) » 16:17
08/13/20
08/13
16:17
08/13/20
16:17
DDS

Dillard's

$27.06 /

+0.195 (+0.73%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DDS Dillard's
$27.06 /

+0.195 (+0.73%)

DDS Dillard's
$27.06 /

+0.195 (+0.73%)

08/03/20 Wedbush
Dillard's price target raised to $26 from $19 at Wedbush
05/15/20 JPMorgan
Dillard's price target lowered to $23 from $32 at JPMorgan
05/07/20 Deutsche Bank
Dillard's price target lowered to $18 from $36 at Deutsche Bank
04/30/20 Wedbush
Dillard's price target lowered to $25 from $63 at Wedbush
DDS Dillard's
$27.06 /

+0.195 (+0.73%)

DDS Dillard's
$27.06 /

+0.195 (+0.73%)

DDS Dillard's
$27.06 /

+0.195 (+0.73%)

Technical Analysis
NASDAQ market internals summary » 16:17
08/13/20
08/13
16:17
08/13/20
16:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume was above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Earnings
Globant reports Q2 non-IFRS diluted EPS 51c, consensus 48c » 16:17
08/13/20
08/13
16:17
08/13/20
16:17
GLOB

Globant

$180.50 /

+6.4 (+3.68%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLOB Globant
$180.50 /

+6.4 (+3.68%)

GLOB Globant
$180.50 /

+6.4 (+3.68%)

07/28/20 Piper Sandler
Globant price target raised to $181 from $152 at Piper Sandler
07/17/20 Cowen
Globant price target raised to $165 from $128 at Cowen
07/03/20 Goldman Sachs
Globant price target raised to $167 from $147 at Goldman Sachs
05/22/20 Piper Sandler
Piper expands Software coverage, favors companies that drive automation
GLOB Globant
$180.50 /

+6.4 (+3.68%)

  • 05
    Jun
GLOB Globant
$180.50 /

+6.4 (+3.68%)

Hot Stocks
Graham awarded $11M in orders for three projects in Asia » 16:16
08/13/20
08/13
16:16
08/13/20
16:16
GHM

Graham

$14.13 /

-0.09 (-0.63%)

Graham Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GHM Graham
$14.13 /

-0.09 (-0.63%)

Earnings
Biolase reports Q2 EPS (12c), consensus (17c) » 16:16
08/13/20
08/13
16:16
08/13/20
16:16
BIOL

Biolase

$0.41 /

-0.0141 (-3.35%)

Reports Q2 revenue $2.9M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIOL Biolase
$0.41 /

-0.0141 (-3.35%)

BIOL Biolase
$0.41 /

-0.0141 (-3.35%)

04/09/20 Dougherty
Biolase supplying ventilators 'highly encouraging,' says Dougherty
BIOL Biolase
$0.41 /

-0.0141 (-3.35%)

  • 25
    Oct
Technical Analysis
NYSE market internals summary » 16:16
08/13/20
08/13
16:16
08/13/20
16:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume was average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Hot Stocks
AudioEye expects to be cash flow positive in 2021 » 16:15
08/13/20
08/13
16:15
08/13/20
16:15
AEYE

AudioEye

$13.50 /

+0.88 (+6.97%)

The company remains…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AEYE AudioEye
$13.50 /

+0.88 (+6.97%)

AEYE AudioEye
$13.50 /

+0.88 (+6.97%)

05/15/20 B. Riley FBR
AudioEye price target raised to $14.50 from $11.50 at B. Riley FBR
10/24/19 National Securities
AudioEye resumed with a Buy at National Securities
AEYE AudioEye
$13.50 /

+0.88 (+6.97%)

AEYE AudioEye
$13.50 /

+0.88 (+6.97%)

Earnings
Good Times Restaurants reports Q3 EPS 2c vs. 4c last year » 16:15
08/13/20
08/13
16:15
08/13/20
16:15
GTIM

Good Times Restaurants

$1.18 /

+0.01 (+0.85%)

Reports Q3 revenue $24.4M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTIM Good Times Restaurants
$1.18 /

+0.01 (+0.85%)

Hot Stocks
Myriad Genetics appoints Paul Diaz as CEO » 16:15
08/13/20
08/13
16:15
08/13/20
16:15
MYGN

Myriad Genetics

$13.38 /

+0.27 (+2.06%)

Myriad Genetics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MYGN Myriad Genetics
$13.38 /

+0.27 (+2.06%)

MYGN Myriad Genetics
$13.38 /

+0.27 (+2.06%)

06/11/20 Piper Sandler
Palmetto coverage language unclear about Myriad's GeneSight, says Piper Sandler
05/06/20 JPMorgan
Myriad Genetics price target lowered to $12 from $14 at JPMorgan
05/06/20 Piper Sandler
Myriad Genetics price target lowered to $14 from $20 at Piper Sandler
03/06/20 JPMorgan
Myriad Genetics price target lowered to $14 from $17 at JPMorgan
MYGN Myriad Genetics
$13.38 /

+0.27 (+2.06%)

Syndicate
Apollo Endosurgery files to sell 20M shares of common stock for holders  16:15
08/13/20
08/13
16:15
08/13/20
16:15
APEN

Apollo Endosurgery

$1.50 /

+ (+0.00%)

 
ShowHide Related Items >><<
APEN Apollo Endosurgery
$1.50 /

+ (+0.00%)

APEN Apollo Endosurgery
$1.50 /

+ (+0.00%)

04/28/20 Piper Sandler
Apollo Endosurgery downgraded to Neutral from Overweight at Piper Sandler
03/27/20 Piper Sandler
Apollo Endosurgery price target lowered to $4.50 from $5.50 at Piper Sandler
11/18/19 Piper Jaffray
Apollo Endosurgery transferred with an Overweight rating at Piper Jaffray
11/18/19 Piper Jaffray
Apollo Endosurgery transferred with an Overweight rating at Piper Jaffray
Earnings
AudioEye reports Q2 EPS (16c), consensus (17c) » 16:15
08/13/20
08/13
16:15
08/13/20
16:15
AEYE

AudioEye

$13.50 /

+0.88 (+6.97%)

Reports Q2 revenue $5.3M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AEYE AudioEye
$13.50 /

+0.88 (+6.97%)

AEYE AudioEye
$13.50 /

+0.88 (+6.97%)

05/15/20 B. Riley FBR
AudioEye price target raised to $14.50 from $11.50 at B. Riley FBR
10/24/19 National Securities
AudioEye resumed with a Buy at National Securities
AEYE AudioEye
$13.50 /

+0.88 (+6.97%)

AEYE AudioEye
$13.50 /

+0.88 (+6.97%)

General news
Week of 8/12 Fed Balance Sheet to be released at 16:30  16:15
08/13/20
08/13
16:15
08/13/20
16:15
 
General news
Week of 8/3 Money Supply to be released at 16:30  16:15
08/13/20
08/13
16:15
08/13/20
16:15
 
Earnings
Regulus reports Q2 EPS (23c), consensus (11c) » 16:14
08/13/20
08/13
16:14
08/13/20
16:14
RGLS

Regulus

$0.63 /

-0.0426 (-6.32%)

Reports Q2 revenue $0,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RGLS Regulus
$0.63 /

-0.0426 (-6.32%)

RGLS Regulus
$0.63 /

-0.0426 (-6.32%)

05/04/20 H.C. Wainwright
Regulus price target lowered to $1.50 from $2 at H.C. Wainwright
09/06/19 H.C. Wainwright
Regulus initiated with a Buy at H.C. Wainwright
RGLS Regulus
$0.63 /

-0.0426 (-6.32%)

Earnings
Quest Resource reports Q2 EPS 8c, consensus (6c) » 16:14
08/13/20
08/13
16:14
08/13/20
16:14
QRHC

Quest Resource

$2.00 /

+ (+0.00%)

Reports Q2 revenue $22M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QRHC Quest Resource
$2.00 /

+ (+0.00%)

Earnings
Armata Pharmaceuticals reports Q2 EPS (26c), consensus (37c) » 16:13
08/13/20
08/13
16:13
08/13/20
16:13
ARMP

Armata Pharmaceuticals

$3.33 /

-0.05 (-1.48%)

Reports Q2 grant revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARMP Armata Pharmaceuticals
$3.33 /

-0.05 (-1.48%)

ARMP Armata Pharmaceuticals
$3.33 /

-0.05 (-1.48%)

05/15/20 H.C. Wainwright
Armata Pharmaceuticals price target lowered to $5 from $9 at H.C. Wainwright
02/06/20 Maxim
Armata Pharmaceuticals initiated with a Buy at Maxim
02/06/20 Maxim
Armata Pharmaceuticals initiated with a Buy at Maxim
01/29/20 H.C. Wainwright
Armata investment removes significant overhang, says H.C. Wainwright
ARMP Armata Pharmaceuticals
$3.33 /

-0.05 (-1.48%)

Earnings
Myriad Genetics reports Q4 adj. EPS (31c), consensus (47c) » 16:12
08/13/20
08/13
16:12
08/13/20
16:12
MYGN

Myriad Genetics

$13.35 /

+0.24 (+1.83%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MYGN Myriad Genetics
$13.35 /

+0.24 (+1.83%)

MYGN Myriad Genetics
$13.35 /

+0.24 (+1.83%)

06/11/20 Piper Sandler
Palmetto coverage language unclear about Myriad's GeneSight, says Piper Sandler
05/06/20 JPMorgan
Myriad Genetics price target lowered to $12 from $14 at JPMorgan
05/06/20 Piper Sandler
Myriad Genetics price target lowered to $14 from $20 at Piper Sandler
03/06/20 JPMorgan
Myriad Genetics price target lowered to $14 from $17 at JPMorgan
MYGN Myriad Genetics
$13.35 /

+0.24 (+1.83%)

Earnings
Acer Therapeutics reports Q2 EPS (56c), consensus (38c) » 16:12
08/13/20
08/13
16:12
08/13/20
16:12
ACER

Acer Therapeutics

$5.20 /

-0.05 (-0.95%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACER Acer Therapeutics
$5.20 /

-0.05 (-0.95%)

ACER Acer Therapeutics
$5.20 /

-0.05 (-0.95%)

ACER Acer Therapeutics
$5.20 /

-0.05 (-0.95%)

Earnings
Arcadia Biosciences reports Q2 EPS ($1.04), consensus (59c) » 16:12
08/13/20
08/13
16:12
08/13/20
16:12
RKDA

Arcadia Biosciences

$3.79 /

-0.07 (-1.81%)

Reports Q2 revenue $281M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RKDA Arcadia Biosciences
$3.79 /

-0.07 (-1.81%)

RKDA Arcadia Biosciences
$3.79 /

-0.07 (-1.81%)

RKDA Arcadia Biosciences
$3.79 /

-0.07 (-1.81%)

RKDA Arcadia Biosciences
$3.79 /

-0.07 (-1.81%)

Earnings
Farfetch sees Q3 adj. EBITDA ($25M) to ($20M) » 16:10
08/13/20
08/13
16:10
08/13/20
16:10
FTCH

Farfetch

$26.39 /

+0.46 (+1.77%)

Sees Q3 digital platform…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FTCH Farfetch
$26.39 /

+0.46 (+1.77%)

FTCH Farfetch
$26.39 /

+0.46 (+1.77%)

08/11/20 Credit Suisse
Farfetch price target raised to $29 from $20 at Credit Suisse
07/14/20 Oppenheimer
Farfetch price target raised to $23 from $16 at Oppenheimer
07/08/20 China Renaissance
Farfetch upgraded to Buy from Hold at China Renaissance
07/01/20 Deutsche Bank
Farfetch price target raised to $23 from $17 at Deutsche Bank
FTCH Farfetch
$26.39 /

+0.46 (+1.77%)

FTCH Farfetch
$26.39 /

+0.46 (+1.77%)

FTCH Farfetch
$26.39 /

+0.46 (+1.77%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.